By:  Susan Heavey, Reuters WASHINGTON, 27 August 2010 – The U.S. Food and Drug Administration is cracking down on use of certain clinical trials that show a new drug is no worse than another already on the market, according to a government report released on Friday. Such trials, known as non-inferiority trials, are used when […]